Survival outcomes in atypical teratoid rhabdoid tumor for patients undergoing radiotherapy in a Surveillance, Epidemiology, and End Results analysis

被引:128
作者
Buscariollo, Daniela L. [1 ]
Park, Henry S. [2 ]
Roberts, Kenneth B. [2 ,3 ]
Yu, James B. [2 ,3 ]
机构
[1] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA
[2] Yale Univ, Sch Med, New Haven, CT USA
[3] Yale Univ, Canc Outcomes Publ Policy & Effectiveness Res COP, New Haven, CT USA
关键词
atypical teratoid rhabdoid tumor; central nervous system; epidemiology; radiotherapy; children; CENTRAL-NERVOUS-SYSTEM; TERATOID/RHABDOID TUMOR; RADIATION-THERAPY; CHILDREN; CHILDHOOD; CHEMOTHERAPY; INFANCY; ATRT;
D O I
10.1002/cncr.27373
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Atypical teratoid rhabdoid tumor (ATRT) is a rare central nervous system malignancy with a poor prognosis that affects mostly young children. Although radiotherapy (RT) historically has been delayed in patients aged <3 years, emerging evidence suggests a role for RT to achieve long-term survivorship. Clinical features and age-dependent trends of RT use were evaluated for patients with ATRT. METHODS: The National Cancer Institute's Surveillance, Epidemiology, and End Results database was used to identify 144 patients with ATRT from 1973 to 2008. The primary endpoint was median overall survival (OS). Clinical and treatment variables were assessed for an association with OS using Cox proportional hazards models. Landmark analysis was used to correct for immortal time bias of adjuvant RT. RESULTS: The median age at diagnosis was 1 year (range, 0-67 years). Gross total resection of the primary tumor was achieved in 39% of patients, and 33% of patients received RT. From 1992 to 2008, RT use increased 2.4-fold in patients aged =3 years. The median OS for was 10 months. In multivariate analyses, metastatic disease (hazard ratio, 2.83; 95% confidence interval, 1.53-5.23; P = .001) and RT (hazard ratio, 0.10; 95% confidence interval, 0.01-0.73; P = .02) were identified as independent predictors of survival. Landmark analysis confirmed a robust association between RT use and survival, which was attenuated in patients ages 4 to 17 years compared with younger patients. CONCLUSIONS: The current results indicated that RT may offer a significant survival benefit for patients with ATRT and that patients aged =3 years may derive more benefit from initial RT compared with older children. The authors concluded that prospective clinical trials are needed to examine the role of RT in the initial management of ATRT in patients aged <3 years. Cancer 2012. (c) 2011 American Cancer Society.
引用
收藏
页码:4212 / 4219
页数:8
相关论文
共 29 条
  • [1] ANALYSIS OF SURVIVAL BY TUMOR RESPONSE
    ANDERSON, JR
    CAIN, KC
    GELBER, RD
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (11) : 710 - 719
  • [2] Childhood Atypical Teratoid Rhabdoid Tumor of the Central Nervous System A Meta-Analysis of Observational Studies
    Athale, Uma H.
    Duckworth, JoAnn
    Odame, Isaac
    Barr, Ronald
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2009, 31 (09) : 651 - 663
  • [3] Atypical teratoid/rhabdoid tumor: short clinical description and insight into possible mechanism of the disease
    Bikowska, B.
    Grajkowska, W.
    Jozwiak, J.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 (06) : 813 - 818
  • [4] Bishop AJ, 2010, INT J RAD ONCOL BIOL
  • [5] Atypical teratoid/rhabdoid tumor of the central nervous system: A highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma - A pediatric oncology group study
    Burger, PC
    Yu, IT
    Tihan, T
    Friedman, HS
    Strother, DR
    Kepner, JL
    Duffner, PK
    Kun, LE
    Perlman, EJ
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1998, 22 (09) : 1083 - 1092
  • [6] Impact of radiotherapy for pediatric CNS atypical teratoid/rhabdoid tumor (single institute experience)
    Chen, YW
    Wong, TT
    Ho, DMT
    Huang, PI
    Chang, KP
    Shiau, CY
    Yen, SH
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 64 (04): : 1038 - 1043
  • [7] Intensive Multimodality Treatment for Children With Newly Diagnosed CNS Atypical Teratoid Rhabdoid Tumor
    Chi, Susan N.
    Zimmerman, Mary Ann
    Yao, Xiaopan
    Cohen, Kenneth J.
    Burger, Peter
    Biegel, Jaclyn A.
    Rorke-Adams, Lucy B.
    Fisher, Michael J.
    Janss, Anna
    Mazewski, Claire
    Goldman, Stewart
    Manley, Peter E.
    Bowers, Daniel C.
    Bendel, Anne
    Rubin, Joshua
    Turner, Christopher D.
    Marcus, Karen J.
    Goumnerova, Liliana
    Ullrich, Nicole J.
    Kieran, Mark W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (03) : 385 - 389
  • [8] DUFFNER PK, 1985, CANCER-AM CANCER SOC, V56, P1841, DOI 10.1002/1097-0142(19851001)56:7+<1841::AID-CNCR2820561325>3.0.CO
  • [9] 2-C
  • [10] Atypical Teratoid or Rhabdoid Tumors: Improved Outcome With High-dose Chemotherapy
    Finkelstein-Shechter, Tal
    Gassas, Adam
    Mabbott, Donald
    Huang, Annie
    Bartels, Ute
    Tabori, Uri
    Laura, Janzen
    Hawkins, Cynthia
    Taylor, Michael
    Bouffet, Eric
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2010, 32 (05) : E182 - E186